You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Adaptive MCM Operations Planning and Replanning(AMORE)
SBC: KNEXUS RESEARCH LLC Topic: N121082The introduction of Littoral Combat Ships (LCS) compounds the already challenging nature of conducting mine countermeasures (MCM) operations, which take place in a dynamic and uncertain operating environment. The MCM Commander (MCMC) needs decision aids to streamline their decision making. To meet this need, we will research and develop a suite of modular algorithms called Adaptive MCM Operations ...
SBIR Phase II 2016 Department of DefenseNavy -
Development of Cad Plating Replacement with Zinc Nickel on High Strength Steel Components
SBC: ENGINEERING AND SOFTWARE SYSTEM SOLUTIONS, INC. Topic: AF071320The aerospace industry commonly uses cad-plated components in aircraft structures, engines, propellers and landing gear systems in both high and low strength steels. Components manufactured from these alloys require sacrificial protective coatings due to their corrosive environments. Cadmium has traditionally been the coating of choice for threaded components and fasteners due to its many desirabl ...
SBIR Phase II 2016 Department of DefenseNavy -
Mitochondrial DNA repair agents for acute lung injury
SBC: EXSCIEN CORPORATION Topic: NHLBIDESCRIPTION provided by applicant Attempts to develop drug treatments for acute lung injury ALI and the acute respiratory distress syndrome ARDS have been marred by unfulfilled expectations Such failures often attributed to the heterogeneous pathophysiology of ALI ARDS and uncertainty about molecular targets of drug action have combined to fuel considerable skepticism about future dru ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Humanized Monoclonal Antibody to Treat Acinetobacter Infections
SBC: BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC Topic: NIAIDDESCRIPTIONprovided by applicantNational surveillance data confirm thatof Abaumannii isolates from US intensive care units are extreme drug resistanceXDRfar higher than other pathogensAt leastandcases of XDR Abaumannii infections occur annually in the US and globallyin developed countriesrespectivelyThese infections result inanddeaths and excess healthcare costs of $million and $million in the US ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine
SBC: SANARIA INC. Topic: RDESCRIPTIONprovided by applicantThe world needs a highly effective malaria vaccineSanaria rPfSPZ Vaccinecomposed of asepticpurifiedcryopreserved radiation attenuated PfSPZprotectedof volunteers in an NIH clinical trialThe vaccine has been administered by direct venous inoculationDVItosubjects in MaliTanzaniaEquatorial GuineaEGand USASafetytolerabilityhigh grade protectionheterologous protection af ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Arenavirus Antiviral Lead Optimization
SBC: ARISAN THERAPEUTICS INC Topic: NIAIDDESCRIPTION provided by applicant Arenaviruses comprise a diverse family Several species are associated with severe arenaviral hemorrhagic fever AVHF in humans that exhibit case fatality rates as high as Human infection with arenaviruses typically occurs through contact with materials contaminated with the excretions of an infected rodent although direct human to human transmission may ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma
SBC: PRESAGE BIOSCIENCES, INC. Topic: 102DESCRIPTIONprovided by applicantImprovements in cancer diagnostics and therapeutics have positively impacted outcomes for oncology patients within select clinical nichesHoweversignificant therapeutic uncertainty awaits the majority of today s oncology patients who present in the clinic with cancer that will relapse after exhibiting an initial response or whose cancer is already refractory to stand ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Advanced morphological analysis of cerebral blood flow for acute concussion diagnosis and return to play determination
SBC: Neural Analytics, Inc. Topic: 101Project Summary Abstract Between and million people each year suffer a mild TBI in the US alone Reliable diagnosis and prompt treatments are vital to managing the often serious short and long term sequelae resulting from mild TBI However a reliable objective and accurate method for mild TBI diagnosis outside of a hospital setting and in particular for determining RTP readiness has e ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
An immune based approach for HIV eradication
SBC: RETROVIROX, INC. Topic: NIAIDDESCRIPTION provided by applicant Viral reservoir eradication has become a leading subject in the field of HIV research A plethora of antiretrovirals ARVs are available to efficiently treat infection Living with HIV has become a chronic disease in which viral load can be controlled in over ninety percent of patients Yet the health social and economical burden of the disease are unpre ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
In Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine
SBC: SANARIA INC. Topic: RDESCRIPTION provided by applicant Sanariaandapos s platform technology is production of aseptic purified cryopreserved Plasmodium falciparum Pf sporozoites SPZ This technology has produced three products administered by needle and syringe all of which are in clinical trials PfSPZ Vaccine radiation attenuated PfSPZ PfSPZ Challenge infectious PfSPZ for controlled human malaria infec ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health